According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...

Innovative diagnostic tools that enhance antibiotic routine monitoring can improve the management of infections caused by antibiotic-resistant bacteria. Therapeutic drug monitoring (TDM) involves ...

Particularly concerning was the emergence of multi-drug resistant strains such as Serratia marcescens, which exhibited complete resistance to several antibiotics and showed only moderate ...

"Even drugs considered last-resort, such as meropenem and amikacin, showed only moderate effectiveness, which is a warning signal for future therapeutic difficulties," he said. Serious threat ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

According to GlobalData, Phase I drugs for Tuberculosis have an 88% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how Amikacin’s ...

Prescription drugs - Drugs to be sold only under the prescription of a Registered Medical Practitioner. Amikacin: Antibacterial Drug Treats Pneumonia, Meningitis, and Multidrug-resistant ...

Background: The combination antimicrobial therapy consisting of amikacin, polymyxin-B, and sulbactam demonstrated in vitro synergy against multi-drug resistant Acinetobacter baumannii. Objectives: The ...

Arikayce (amikacin liposome inhalation suspension) is a brand-name oral nebulizer that’s prescribed for a type of lung infection in certain adults. The cost of the drug with and without ...